Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
12/2005
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282804 Process for preparing 10alpha-[4'-(S,S-dioxothiomorpholin-1'-yl)]-10-deoxo-10-dihydroartemisinin
12/22/2005US20050282710 Substituted benzoylcyclohexanediones as herbicides
12/21/2005EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols
12/21/2005EP1465898B1 Biocidal compounds and their preparation
12/21/2005CN1232522C Synthesis method for preparation of psoralen
12/21/2005CN1232517C Anti-cancer active substance of cyathocline purpurea and separating and purifying method thereof
12/21/2005CN1232515C Reworkable composition of oxirane (S) or thiirane (S)-containing resin and curing agent
12/15/2005WO2005118777A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
12/15/2005WO2005118576A1 Constrained himbacine analogs as thrombin receptor antagonists
12/15/2005WO2005118566A1 Method for producing 1,3-dioxolan-4,6-dione compound
12/15/2005WO2005118531A1 Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake
12/15/2005CA2822994A1 Intermediates for the preparation of analogs of halichondrin b
12/15/2005CA2568415A1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
12/14/2005EP1604992A1 Process for the preparation of 10alpha-[4'-(S-S-Dioxothothiomorpholin-1'-yl)]-10-Deoxo-10-Dihydroartemisinin
12/14/2005EP1604661A1 Remedy for corneal ulcer
12/14/2005EP1603557A2 Synthesis of peloruside a and analogs thereof for use as antitumor agents
12/14/2005EP1603555A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents
12/14/2005CN1706847A Process for preparing 10alpha-[4'-(s,s-dioxothiomorpholin-1'-yl)]-10-deoxo-10-dihydroartemisinin
12/14/2005CN1706846A Synthesis process of 4,4'-diphenyl ether tetraformic acid dihydride
12/14/2005CN1231480C 1,2,3-thiadiazole carboxylic acid (thio) esters and use thereof as pest control agent or as microbicide
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/13/2005US6974806 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/08/2005WO2005116036A1 Curcumol derivatives, the compositions comprising the same and the use of the same in the manufacture of medicament
12/08/2005WO2005116006A1 Method for producing fullerene derivative
12/08/2005WO2005048921A3 Bicyclic carbohydrates for the treatment of infections caused by the alphaherpesvirinae hsv-1 and hsv-2
12/08/2005WO2005047526A3 Method for identifying inhibitors using a homology model of polo-like kinase 1
12/08/2005WO2005041881A3 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
12/08/2005US20050272731 stereospecific saponification of a racemic ester using a lipase enzyme, then reduction of a beta -keto amide and esters, to form chemical intermediate for 16-membered macrolide rings used as antitumor agents
12/08/2005US20050272716 Use of parthenolide derivatives as antileukemic and cytotoxic agents
12/08/2005US20050272132 For therapy of a fungal infection
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705668A Heterocyclocarboxamide derivatives
12/07/2005CN1705662A Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
12/07/2005CN1705658A Process for making spirolactone compounds
12/07/2005CN1704417A Novel curcumenol derivatives
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972306 Useful as nucleating agents and especially useful for improving optical properties of polymeric materials
12/06/2005CA2289599C Substituted heterocyclic compounds, method for preparing and compositions containing same
12/06/2005CA2013524C Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
12/01/2005US20050267156 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
12/01/2005US20050267155 Constrained himbacine analogs as thrombin receptor antagonists
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267074 Resistance-repellent retroviral protease inhibitors
12/01/2005US20050267048 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
11/2005
11/30/2005EP1599485A2 Podophyllotoxin derivatives as antitumor agents
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005CN1702071A Optical diamine monomer containing di-dehydrated-hexitol unit and process for preparing same
11/30/2005CN1229502C Fermentative preparation process for cytostatics and crystal form thereof
11/30/2005CN1229380C Prepn. process of spiroacetal derivative
11/30/2005CN1229379C Method for purifying a composition, isosorbide or isomannite, and use thereof
11/30/2005CN1229376C 1,7-disubstituted perylene-3,4,9.10-tetracarboxylic acid diimide, its preparation and use
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/24/2005WO2005111134A2 Method of nucleating a polyolefin composition with acetal-based compounds
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110428A2 Resistance-repellent retroviral protease inhibitors
11/24/2005WO2005084222A3 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
11/24/2005US20050261507 Preparation of stereoisomers of (3alpha/beta, 6alpha/beta)hexahydrofuro[2,3-b]furan-3-ol
11/24/2005US20050261506 Process for producing spiroglycol
11/24/2005US20050261364 Stereoisomeric form and a second antiretroviral compound; treating multidrug resistant HIV infections; protein plasma binding of the protease inhibitor has minimal or no effect on its potency; effective over a broad range of HIV mutants, bioavailability
11/24/2005US20050261363 Acetone extraction for gamboge resins for tumor purification for antitumor and anticancer agent cells with acetone extraction
11/24/2005DE4205306B4 Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden Acid amides, drugs with the same and method for the preparation of acid amides
11/24/2005CA2566340A1 Resistance-repellent retroviral protease inhibitors
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/23/2005EP1598357A1 Process for the production of the spiroglycol 3,9-bis(1,1-dimethyl-2-hydroxyethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane
11/23/2005EP1597263A1 Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide a
11/23/2005EP1597084A2 Imaging system
11/23/2005EP1596855A2 Methods and compositions for use in treating cancer
11/23/2005CN1699370A Artesunate salt and its preparation process and use
11/23/2005CN1699369A Podophyllotoxin compounds and their application and preparation process
11/23/2005CN1699368A Compounds separated from gamboges with activities of inhibiting tumour/cancer cell growth and pharmaceutical compositions containing same
11/22/2005CA2277100C Cyclic sulfone derivatives
11/22/2005CA2162606C Method for preparing erythruronolactone
11/17/2005WO2005108479A2 Acetal-based compositions
11/17/2005WO2005107742A1 Novel antiviral helioxanthin analogs
11/17/2005US20050256322 Deprotecting and cyclizing an optionally substituted 3-(dioxolan-4-yl)-2-tetrahydrofuranol with hydrochloric acid, sulfuric acid, phosphoric acid, methanesulfonic acid, p-toluenesulfonic acid, or a strong acidic ion-exchange resin to form 3-hydroxyhexahydrofuro(2,3-b)furan
11/17/2005US20050256185 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/17/2005US20050256183 Hsp90-inhibiting zearalanol compounds and methods of producing and using same
11/17/2005US20050256048 Selective androgen receptor modulators and methods for their identification, design and use
11/16/2005EP1594877A2 Process for the production of 2-oxa-3-one androstane derivatives
11/16/2005EP1594835A2 Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses
11/16/2005EP1594491A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
11/16/2005EP1416949A4 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
11/16/2005EP0979089B1 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells
11/15/2005US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents
11/10/2005WO2005105807A1 Process for producing pentacyclic taxane
11/10/2005WO2005105805A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof
11/10/2005WO2005105075A1 Tri-substitued 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
11/10/2005US20050250845 Pseudopolymorphic forms of a hiv protease inhibitor
11/10/2005US20050250811 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/10/2005US20050250751 neo-tanshinlactone is excluded; treating cancer
11/10/2005DE102005016985A1 New as-indacene derivatives useful in liquid crystal media for electrooptic displays
11/10/2005CA2565013A1 Method for producing pentacyclic taxans
11/10/2005CA2563161A1 Tri-substitued 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstited pyran derivatives
11/09/2005EP1593683A2 Dihydro-2,3-Benzodiazepine derivatives
11/09/2005EP1592692A1 Process to prepare malayamycin derivatives
11/09/2005EP1368025B1 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
11/09/2005EP1019389B1 Epothilone derivatives
11/09/2005EP0918775B1 Phenyl-substituted cyclic ketoenol
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 174